Prospective Clinical Trial of HIV+ Living Donor Kidney Donation for HIV+ Recipients

Analytical Treatment Interruption in HIV Positive Patients

NCT02590354 ·Status: COMPLETED ·Phase: NA

Double Protease Inhibitor to Darunavir Switch Study

NCT00531557 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic Hemodialysis

NCT02600819 ·Status: COMPLETED ·Phase: PHASE3

Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD

NCT04311944 ·Status: UNKNOWN ·Phase: NA

Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years

NCT03405935 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.

NCT01328041 ·Status: COMPLETED ·Phase: PHASE3

HIV Sequencing After Treatment Interruption to Identify the Clinically Relevant Anatomical Reservoir

NCT02641756 ·Status: COMPLETED ·Phase: NA

Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen

NCT02478632 ·Status: COMPLETED ·Phase: PHASE3

Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection

NCT03449706 ·Status: RECRUITING

Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients

NCT03360682 ·Status: COMPLETED ·Phase: PHASE4

DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection

NCT06203132 ·Status: RECRUITING ·Phase: PHASE3

First in Human Study of TLC-ART 101 (ACTU 2001)

NCT05850728 ·Status: COMPLETED ·Phase: PHASE1

Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients

NCT00551655 ·Status: COMPLETED

Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF

NCT02121795 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Two Tests for Anti-HIV Drug Resistance

NCT00006490 ·Status: COMPLETED

Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus

NCT00321438 ·Status: TERMINATED

Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir

NCT02337322 ·Status: UNKNOWN ·Phase: PHASE4

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

NCT00102934 ·Status: UNKNOWN ·Phase: NA

Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I

NCT02616029 ·Status: COMPLETED ·Phase: PHASE3

2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial

NCT04553081 ·Status: RECRUITING ·Phase: PHASE4

A Comparison of Two Anti-HIV Treatment Plans

NCT00005915 ·Status: COMPLETED

Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients

NCT00128908 ·Status: TERMINATED ·Phase: PHASE4

Observational Study of Treated and Untreated Acute and Early HIV-1 Infection

NCT00219934 ·Status: COMPLETED

Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults

NCT02246998 ·Status: COMPLETED ·Phase: PHASE4

Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept.

NCT03539224 ·Status: UNKNOWN ·Phase: PHASE2